Teva Malta
Generic pharmaceutical manufacturing in the heart of Europe
Teva Malta (formerly Actavis Malta) is a pharmaceutical manufacturing facility operating under the global Teva Pharmaceuticals brand. The Malta plant manufactures a range of generic medicines and pharmaceutical products, operating under strict GMP standards and supplying markets across Europe.
- Type
- Manufacturer
- Location
- Bulebel Industrial Estate, Malta
- Website
- actavis.com.mt
- Categories
- Medical & Healthcare Supplies, Supplements & Wellness
- Markets
- Malta, United Kingdom
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-03 Mail server of the company domain
- sanctions-clear (green), checked 2026-08-03 OpenSanctions
- web-presence-since (green), checked 2026-08-04 Internet Archive (Wayback)
- debarment-clear (green), checked 2026-08-03 OpenSanctions
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)